IDXX Dividend: IDEXX Laboratories Inc Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	4,167	3,897	3,660	3,367	3,215	2,706
Revenue Growth (YoY)	8%	6%	9%	5%	19%	12%
Cost of Revenue	1,595	1,518	1,470	1,362	1,325	1,135
Gross Profit	2,572	2,378	2,189	2,004	1,889	1,571
Selling, General & Admin	1,023	1,026	900	847	794	734
Research & Development	242	219	190	254	161	141
Operating Expenses	1,266	1,246	1,091	1,102	955	875
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	1,273	1,109	1,061	859	902	661
Income Tax Expense	246	221	216	180	157	79
Net Income	1,027	887	845	679	744	581
Net Income Growth	19%	5%	24%	-9%	28%	36%
Shares Outstanding (Diluted)	80.67	83.24	83.97	84.6	86.57	86.72
Shares Change (YoY)	-3%	-1%	-1%	-2%	0%	-1%
EPS (Diluted)	12.73	10.67	10.06	8.03	8.6	6.71
EPS Growth	22%	6%	25%	-7%	28%	37%
Free Cash Flow	940	798	772	384	635	540
Free Cash Flow Per Share	11.65	9.58	9.19	4.53	7.33	6.22
Gross Margin	61.72%	61.02%	59.8%	59.51%	58.75%	58.05%
Operating Margin	31.34%	29.04%	30%	26.78%	29.05%	25.68%
Profit Margin	24.64%	22.76%	23.08%	20.16%	23.14%	21.47%
Free Cash Flow Margin	22.55%	20.47%	21.09%	11.4%	19.75%	19.95%
EBITDA	1,446	1,261	1,212	1,013	1,038	790
EBITDA Margin	34.7%	32.35%	33.11%	30.08%	32.28%	29.19%
D&A For EBITDA	140	129	114	111	104	95
EBIT	1,306	1,132	1,098	902	934	695
EBIT Margin	31.34%	29.04%	30%	26.78%	29.05%	25.68%
Effective Tax Rate	19.32%	19.92%	20.35%	20.95%	17.4%	11.95%

Follow-Up Questions











